Learn how machine learning and clinico-genomic data from 500,000 cancer cases are being utilized to advance cancer care and drug discovery in this 48-minute symposium talk delivered by Nicolas Stransky, Corporate Vice-President of Data Science at Caris Life Sciences, as part of the Machine Learning in Drug Discovery Symposium at the Broad Institute.
Leveraging Machine Learning and Clinico-Genomic Data for Cancer Care and Drug Discovery
Overview
Syllabus
Machine Learning in Drug Discovery Symposium - Nicolas Stransky
Taught by
Broad Institute
Related Courses
-
Decoding Biology with Data Abundance - Machine Learning in Drug Discovery
-
Python for Bioinformatics - Drug Discovery Using Machine Learning and Data Analysis
4.5 -
Introduction to Proteogenomics
-
Generative AI for Drug Discovery Hit Identification and Optimization
-
Machine Learning for Protein Engineering in Drug Discovery
-
Harnessing AI for Drug Discovery: From Property Prediction to Molecular Design
